Seres Therapeutics Earnings
NASDAQ: MCRBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.71+0.08 (+3.04%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Wed, Nov 4, 2026
Fiscal period
Sep/2026
EPS estimate
$-1.34
Seres Therapeutics earnings summary
Seres Therapeutics is scheduled to report Sep/2026 earnings on Nov 4, 2026, with analysts expecting EPS of $-1.34.
Summary generated from market data by MetaCap's automated system. Methodology